Page last updated: 2024-11-01

norfloxacin and Pelvic Inflammatory Disease

norfloxacin has been researched along with Pelvic Inflammatory Disease in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Pelvic Inflammatory Disease: A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Surico, N1
Tavassoli, K1

Other Studies

1 other study available for norfloxacin and Pelvic Inflammatory Disease

ArticleYear
[Etiopathogenetic interpretation of urinary tract infections associated with pelvic inflammatory disease and a clinico-therapeutic study of the effects of norfloxacin].
    Minerva ginecologica, 1988, Volume: 40, Issue:3

    Topics: Adolescent; Bacteria; Female; Humans; Norfloxacin; Pelvic Inflammatory Disease; Urinary Tract Infect

1988